
OncoCyte Corporation (NASDAQ:OCX) Q4 2024 Earnings Call Transcript
OncoCyte Corporation (NASDAQ:OCX) Q4 2024 Earnings Call Transcript March 24, 2025 OncoCyte Corporation misses on earnings expectations. Reported EPS is $-1.92791 EPS, expectations were $-0.4. Gabby Woody: Joining us today are Oncocyte President and CEO, …